Product NDC: | 61748-012 |
Proprietary Name: | Pyrazinamide |
Non Proprietary Name: | Pyrazinamide |
Active Ingredient(s): | 500 mg/1 & nbsp; Pyrazinamide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61748-012 |
Labeler Name: | VersaPharm Incorporated |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA081319 |
Marketing Category: | ANDA |
Start Marketing Date: | 19950401 |
Package NDC: | 61748-012-11 |
Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (61748-012-11) > 10 TABLET in 1 BLISTER PACK |
NDC Code | 61748-012-11 |
Proprietary Name | Pyrazinamide |
Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (61748-012-11) > 10 TABLET in 1 BLISTER PACK |
Product NDC | 61748-012 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pyrazinamide |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19950401 |
Marketing Category Name | ANDA |
Labeler Name | VersaPharm Incorporated |
Substance Name | PYRAZINAMIDE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antimycobacterial [EPC] |